| |||||||||||||
| |||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
Zydus Cadila has received the final approval from the USFDA to market Clobazam Tablets, (US RLD-ONFI Tablet), 10 mg and 20 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. |
|
|
|
Home |
Shares |
F&O |
Mutual Funds |
Loans |
Insurance |
News Centre Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Advertise © All rights reserved. IRIS Business Services Limited A Disclaimer |
| |||||||||||||
| |||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
|
|
|
|
Home |
Shares |
F&O |
Mutual Funds |
Loans |
Insurance |
News Centre Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Advertise © All rights reserved. IRIS Business Services Limited A Disclaimer |